Pixie Dust Technologies (PXDT) Stock Price, News & Analysis

Company Overview

Pixie Dust Technologies, Inc., a technology company, focuses on personal care and diversity, and workspace and digital transformation businesses primarily in Japan. It offers SonoRepro, an ultrasonic non-contact vibrotactile stimulation scalp care device; VUEVO, a series of directional voice arrival detection devices for individuals with deaf and hard-of-hearing; and kikippa, an acoustic stimulation device functioning as a desk-top speaker. The company also provides iwasemi, a sound-absorbing or sound-proofing material for architectural and interior design firms; hackke, a location positioning technology; KOTOWARI, a technology offering spatial analysis data; and magickiri, a planning services and monitoring service, which monitors human behavior and analyzes the customer's environment on the customer's behalf. In addition, it operates Pixie Nest, a membership forum, which hosts meetings and distributes information to facilitate solving social issues. The company was incorporated in 2017 and is headquartered in Tokyo, Japan.

Key Stats

• Today's Range: $0.42 to $0.75
• 50-Day Range: $0.45 to $2.26
• 52-Week Range: $0.40 to $8.69
• Volume: 1.76 million shs
• Average Volume: 827,728 shs
• Market Capitalization: $8.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.21
• Consensus Rating: Buy

Pixie Dust Technologies Stock Analysis - MarketRank™

Pixie Dust Technologies scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Pixie Dust Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Pixie Dust Technologies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Pixie Dust Technologies has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.35% of the outstanding shares of Pixie Dust Technologies have been sold short.

Short Interest Ratio / Days to Cover

Pixie Dust Technologies has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Pixie Dust Technologies has recently increased by 2,576.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Pixie Dust Technologies does not currently pay a dividend.

Dividend Growth

Pixie Dust Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.35% of the outstanding shares of Pixie Dust Technologies have been sold short.

Short Interest Ratio / Days to Cover

Pixie Dust Technologies has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Pixie Dust Technologies has recently increased by 2,576.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.43

News Sentiment

Pixie Dust Technologies has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Pixie Dust Technologies this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Pixie Dust Technologies insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.39% of the stock of Pixie Dust Technologies is held by institutions.

PXDT Stock Analysis - Frequently Asked Questions

How have PXDT shares performed this year?

Pixie Dust Technologies' stock was trading at $6.98 at the start of the year. Since then, PXDT stock has decreased by 91.7% and is now trading at $0.5799.
View the best growth stocks for 2024 here.

When did Pixie Dust Technologies IPO?

Pixie Dust Technologies (PXDT) raised $15 million in an initial public offering on Tuesday, August 1st 2023. The company issued 1,666,667 shares at a price of $9.00 per share.

How do I buy shares of Pixie Dust Technologies?

Shares of PXDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Pixie Dust Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pixie Dust Technologies investors own include Intel (INTC), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and AutoZone (AZO).

Company Calendar

• Today: 11/17/2024
• Next Earnings (Estimated): 11/28/2024
• Fiscal Year End: 4/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:PXDT
• Previous Symbol: NASDAQ:PXDT
• CUSIP: N/A
• CIK: 1962845
• Web: pixiedusttech.com
• Phone: 810352444880
• Fax: N/A
• Employees: 78
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $5.21
• High Stock Price Target: $5.21
• Low Stock Price Target: $5.21
• Potential Upside/Downside: +798.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.71
• Current Ratio: 4.88
• Quick Ratio: 4.53

Sales & Book Value

• Annual Sales: $6.30 million
• Price / Sales: 1.37
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.62 per share
• Price / Book: 0.94

Miscellaneous

• Outstanding Shares: 14,870,000
• Free Float: N/A
• Market Cap: $8.62 million
• Optionable: Not Optionable
• Beta: -0.25